8-K: Merit Medical Announces Preliminary Unaudited Revenue for 2024, Projects 7.7%-7.9% Growth

Merit Medical Systems reports preliminary unaudited revenue for 2024 in the range of $1.355 billion to $1.357 billion, projecting a year-over-year increase of approximately 7.7% to 7.9%.

Summary

• Merit Medical Systems, Inc. announced preliminary unaudited revenue for the year ended December 31, 2024.
• The company expects revenue to be in the range of $1.355 billion to $1.357 billion.
• This represents an approximate 7.7% to 7.9% increase compared to the revenue reported for the year ended December 31, 2023.
• Preliminary constant currency revenue increased in the range of approximately 8.4% to 8.6% compared to the prior year period.
• Merit plans to announce its full financial results for the fourth quarter and year-end 2024, and issue fiscal year 2025 guidance on February 25, 2025.
• An investor conference call will be held on the same day.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the expected revenue growth and the announcement of the date for the full financial results and guidance. However, the preliminary nature of the results and the cautionary statements temper the enthusiasm.

Positives

• Merit Medical anticipates revenue growth of 7.7% to 7.9% for 2024.
• Constant currency revenue is expected to increase by 8.4% to 8.6%.

Risks

• The preliminary revenue information is based on the company's current expectations and may be adjusted upon completion of financial review and audit procedures.
• The announcement includes a cautionary statement regarding forward-looking statements, highlighting various risks and uncertainties that could affect actual results, as detailed in the company's 2023 Annual Report on Form 10-K and other SEC filings.

Future Outlook

Merit Medical plans to announce its financial results for the quarter and year ended December 31, 2024, and issue fiscal year 2025 guidance on February 25, 2025.

Industry Context

The announcement reflects Merit Medical's position as a leading global manufacturer and marketer of healthcare technology, particularly in interventional, diagnostic, and therapeutic procedures.

Stakeholder Impact

• Shareholders can anticipate further details on the company's performance and future outlook on February 25, 2025.
• The projected revenue growth may positively influence investor confidence.

Next Steps

• Merit Medical will announce its full financial results for Q4 and year-end 2024 on February 25, 2025.
• The company will hold an investor conference call on February 25, 2025.

Key Dates